Immunohistochemistry revealed that, in CXCL1+TNBCs, the cellular sources of CXCL1 included, in addition to CD133+BCSCs (Park et al., 2010), tumor infiltrating immune cells, such as CD68+ macrophages (Figure 3E), and the vast majority of BC cells. This evidence concerns the gene CD68 and breast cancer.